Since 1992, ISCT has been the leading global forum and resource for developing and supporting innovative cellular therapies through communication, education, and training.
ISCT members are:
Investigators, clinicians, technologists, regulators and industry working in the field of cellular therapy and related fields, as well as employees of laboratories and businesses working in or supplying goods or services to the field. Experts in the whole spectrum of tissue research and all cell types, including hematopoietic and mesenchymal stem cells
ISCT is a global forum of leading cell therapy experts from 40 countries who drive educational and regulatory activities across all continents. We have regional leadership infrastructure in Asia, South America, Australia, Europe, and North America that drive regional educational and regulatory initiatives.
ISCT’s Executive Committee comprises world-class scientists, clinicians, technologists, and regulatory professionals from around the globe.
ISCT is the principal cell therapy society and the only group focused on pre-clinical and translational aspects of developing cell therapy products. As such, ISCT helps the academic, government, and biotech/pharma sectors transform research into practice and product.
Education and Training
ISCT supports cell therapy education and training for lab techs, MDs, PhDs, and all others in the field. Our regional, national, and international meetings, along with our publications and webinars, provide educational material and presentations on the most current issues in the field.
Working with Regulators
ISCT represents its membership in driving and informing the development of national and international regulatory environments. This mandate is supported by active Regulatory Affairs committees in North America, Europe, and Asia. In the USA, ISCT leads key meetings to ensure information exchange with regulatory bodies and works closely with the FDA to represent members’ issues and positions.
Working with Industry
Commercial entities bear much of the responsibility for translating cell therapy research into clinical products. The ISCT Commercialization Committee aims to address questions related to the commercialization of cell therapies, maintain an “industry stakeholder network” that will function as a focus group for ISCT and allow business-to-business networking within the sector, and identify issues relating to the growth of the cell therapy market.